It is well known that in the pathology of Alzheimer’s disease, there is a condition of generalized and progressive inflammation during its evolution, both occurring in the brain system, then endothelial cells expressing CX3CL1 and its receptor CX3CR1. Here, CX3CL1 is linked to early-onset autosomal dominant Alzheimer disease.